Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5865_Библиотеки_им_академика_М_И_Перельмана.pdf

Preface
The Applicability Domain (AD) of QSAR models is an important issue to check while predicting a
new set of compounds using previously developed QSAR models. AD allows one to estimate the uncertainty in the prediction of a particular compound based on how similar it is to the training compounds
that are used in the model development. Chapter 5 entitled “Importance of Applicability Domain of
QSAR Models” and contributed by Kunal Roy and Supratik Kar defines the concept of applicability
domain of QSAR models. Different approaches of determining AD of QSAR models (based on ranges
in the descriptor space, geometry, distance, probability density distribution, and range of the response
variable) are elaborated. Some practical examples of the determination of AD are also added. The future
research direction is indicated.
The application of QSAR has been applied to different chemical classes of diverse applications. Antioxidants are an important class of chemicals with great bio-medicinal importance. Chapter 6 (“QSAR
of Antioxidants”), contributed by Omar Deeb and Mohammad Goodarzi, discusses the applications of
QSAR in modeling of antioxidant compounds. This chapter starts with an introductory discussion on
antioxidants, their mechanism of action, and methods of determination of antioxidant activity. Then the
concepts of QSAR, descriptors and statistical methods and validation strategies are briefly reviewed.
Finally, the authors discuss the recent QSAR reports on antioxidants and comment on the structureantioxidant activity relationships.
Though QSAR was originally developed in the context of physical organic chemistry, it has been
applied very extensively to chemicals (drugs) with action on the biological systems. The applications
of QSAR in medicinal chemistry have addressed design and development of potential ligands active
against different diseases and health problems. The need for development of new drugs may arise due
to emergence of new diseases or reduction of therapeutic efficacy of older candidates in a particular
disease condition of increased complexity or emergence of drug resistance. Development of resistance
of bacterial pathogens to various antimicrobial agents is an issue of high concern. One of the primary
mechanisms of drug resistance is extrusion of the foreign chemical through bacterial efflux pump. To
fight against multidrug efflux systems, one possible practice is the combination of conventional antimicrobial agents with small molecules known as multidrug efflux pump inhibitors. Chapter 7 (“QSAR
Studies on Bacterial Efflux Pump Inhibitors”), contributed by Khac-Minh Thai, Trong-Nhat Do, ThuyViet-Phuong Nguyen, Khanh-Tho D Nguyen, and Thanh-Dao Tran, deals with QSAR modeling studies
for bacterial efflux pump inhibitors. The chapter starts with an introduction on antibiotic resistance and
role of bacterial efflux pumps in development of the resistance. Then various bacterial efflux pump
inhibitors and targets for designing new efflux pump inhibitors are discussed. Finally, QSAR approaches
for the design of new efflux pump inhibitors are presented.
Tuberculosis is a major health problem in the developing countries and second only to Acquired Immuno Deficiency Syndrome (AIDS) as the notorious killer worldwide due to a single infectious agent.
Chapter 8 (“Integrated in Silico Methods for the Design and Optimization of Novel Drug Candidates: A
Case Study on Fluoroquinolones – Mycobacterium Tuberculosis DNA Gyrase Inhibitors”), contributed by
Nikola Minovski and Marjana Novič, provides a comprehensive overview of some of the current trends
and advances in the in silico design of novel drug candidates with a special emphasis on 6-fluoroquino-
lone antibacterials as potential novel Mycobacterium tuberculosis DNA gyrase inhibitors. The authors
start the chapter by presenting a classical industrial drug discovery pipeline followed by a brief mention
xx
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Preface
of different in silico drug design strategies. Then the authors present a QSAR-aided integrated in silico
approach for small-scale ligand screening and virtual combinatorial library design. The authors then
present a novel and simple semi-automated Boolean-based clustering method for hit(s) identification.
To demonstrate the practical implementation of the suggested integrated in silico screening protocol, the
authors present a specific example related to the design and identification of novel 6-fluoroquinolone
antibacterials as potential inhibitors against M. tuberculosis DNA gyrase enzyme.
Hepatitis C, a chronic blood-borne virus infection, is a global concern. It is likely that we will see more
mortality from this disease in the coming years. Nonstructural 5B (NS5B) polymerase and nonstructural
3/4A (NS3/4a) protease have been found to be promising targets for the development of anti-HCV (Hepatitis C Virus) agents. In Chapter 9 (“Computational Approaches for the Discovery of Novel Hepatitis C
Virus NS3/4a and NS5B Inhibitors”), authored by Khac-Minh Thai, Quoc-Hiep Dong, Thi-Thanh-Lan
Nguyen, Duy-Phong Le, Minh-Tri Le and Thanh-Dao Tran, different computational approaches including
QSAR and virtual screening for anti-HCV drug discovery are discussed. At the beginning, the authors
describe HCV genome, HCV structural and nonstructural proteins. Then the authors briefly introduce
various computational modeling techniques, including QSAR, pharmacophore, and docking analyses.
The authors then review different applications of QSAR and virtual screening approaches for developing
NS5B polymerase inhibitors and NS3/4a protease inhibitors. The QSAR approach in the discovery for
multi-target inhibitors of HCV is also described.
Alzheimer’s disease is the most common form of dementia, with chronic, irreversible, and progressive neurodegenerative disorder. The acetylcholinesterase enzyme is an important target for development
of drugs for the treatment of Alzheimer’s disease. Chapter 10 (“QSAR Models towards Cholinesterase
Inhibitors for the Treatment of Alzheimer’s Disease”), authored by C Gopi Mohan and Sikhar Gupta,
presents an overview of different QSAR studies carried out for a variety of cholinesterase inhibitors
for the treatment of Alzheimer’s disease. In the introduction, the authors discuss Alzheimer’s disease
and its etiologies, and then they discuss the structural aspects of the acetylcholinesterase enzyme followed by an account of different acetylcholinesterase inhibitors. A brief account of theories of QSAR,
descriptors, different linear and non-linear modeling methods is then given. Finally, QSAR reports on
acetylcholinesterase inhibitors for development of anti-Alzheimer’s drugs are reviewed.
Cancer is a group of diseases that presents a widespread fear in society. There are several forms of
cancer that can develop from almost any type of cell in the body. Breast carcinoma is a common form of
cancer in females, accounting for about 20% of all cancer-related deaths. Being overexpressed in breast
cancer and responsible for estrogen production, aromatase is a potential target for designing anti-breast
cancer drugs. Chapter 11 (“Ligand- and Structure-Based Drug Design of Non-Steroidal Aromatase
Inhibitors [NSAIs] in Breast Cancer”), authored by Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder,
Chanchal Mondal, and Achintya Saha, discusses the design of nonsteroidal aromatase inhibitors using
QSAR and receptor-based approaches. In the Introduction of the chapter, the authors discuss breast cancer
and its treatments. Then the authors highlight biochemistry, structure, and gene expression of aromatase.
The authors then mention different types of aromatase inhibitors. Finally, in silico modeling studies of
aromatase inhibitors using both ligand- and structure-based approaches are reviewed.
Predictive toxicology is an important area of application of QSAR. With any amount of resources available, it is impossible to experimentally evaluate the toxicity potential of tens of thousands of compounds
against all available toxicity endpoints. Then it becomes necessary to rely on the validated computational
models for risk assessment of industrial and other chemicals. Chapter 12 (“Computational Techniques
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
xxi

Preface
Application in Environmental Exposure Assessment”), authored by Karolina Jagiello and Tomasz Puzyn,
presents an overview of the application of computational techniques in environmental exposure assessment.
In the Introduction, the authors highlight the importance of computational toxicology in the light of REACH
regulations. Then the authors briefly introduce the QSAR methodology and validation tools. Multimedia
mass-balance modeling and QSAR modeling for the environmental exposure assessment are described. A
novel method linking multimedia mass-balance and QSAR are also commented on. The authors finally give
their opinion on future possibilities of computational techniques for environmental exposure assessment.
Apart from drug discovery and predictive toxicology, the QSAR principles have also been applied
in material science. Different properties and activities of various types of materials have been modeled
using quantitative structure-property relationships. Nanotechnology is a newly emerging field in the
st
century. Nanomaterials have tremendous application potential in medicine, cosmetics, electron-
21
ics, biomaterials, and energy production. However, the toxicity of nanomaterials to living organisms
and the environment still remains relatively unknown. Thus, it is necessary to evaluate the potential
adverse effects of nanomaterials to humans and the environment. Chapter 13 (“QSAR-Based Studies of
Nanomaterials in the Environment”), authored by Valeria V. Kleandrova, Feng Luan, Alejandro SpeckPlanche, and M. Natália D. S. Cordeiro, provides an overview of in silico approaches for the prediction
of environmental toxicity of nanomaterials. At the beginning, the authors focus on the environmental
risk of nanomaterials. Then the authors review in silico studies of environmental effects of nanomaterials
including classical type QSAR models and perturbation models. The authors also present a case study
of unified QSAR-perturbation model, demonstrating its ability to predict ecotoxicity of nanoparticles
under diverse experimental conditions.
We have another contributed chapter on the computational risk assessment of nanomaterials. In
Chapter 14 (“Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of
NanoMaterials”), authored by Eleni Vrontakia, Thomas Mavromoustakos, Georgia Melagraki, and
Antreas Afantitis, recent studies on predictive quantitative nano-structure activity relationship models
for the risk assessment of nanomaterials are reviewed. The authors initially discuss the impact of nanotechnological innovations in modern society. The authors then indicate the need to evaluate the toxicity
potential of nanomaterials. With a brief introduction to the basic workflow of QSAR modeling, the
authors review QSAR reports on nanomaterial toxicity. The authors also give their opinion on the future
of computational nanotoxicology.
QSAR practitioners have to rely on the software tools for developing validated and predictive models
for possible application on new sets of data. Thus, access to validated software tools is a prerequisite for
QSAR research in the present-day scenario. Most of the useful software tools are commercial, while only
few tools are available free. Chapter 15 (“QSPR/QSAR Analyses by Means of the CORAL Software:
Results, Challenges, Perspectives), authored by Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati,
Orazio Nicolotti, Angelo Carotti, Karel Nesmerak, Aleksandar M. Veselinović, Jovana B. Veselinović,
Pablo R. Duchowicz, Daniel Bacelo, Eduardo A. Castro, Bakhtiyor F. Rasulev, Danuta Leszczynska, and
Jerzy Leszczynski, presents a freeware tool, CORAL, for QSAR model development. The authors at first
introduce some basic concepts of QSAR followed by a discussion on the technical details of CORAL.
Then the authors discuss several QSAR/QSPR studies made using the CORAL software reported over
the past few years. Finally, the authors indicate some problems associated with the CORAL software
and mention the future directions.
xxii
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Preface
In the above 15 chapters, different aspects of theory and applications of QSAR and recent developments are discussed. This book covers the basic principles and tools used in QSAR (Chapter 1), novel
descriptors (Chapters 2, 3, and 4), tests for applicability domain (Chapter 5), applications of QSARs for
optimization of structures of bioactive compounds (Chapter 6), modeling of drug candidates for potential
therapeutic targets in the context of drug discovery (Chapters 7-11), risk assessment of chemicals in the
context of environmental safety (Chapter 12), evaluation of toxicity of nano-materials in the context of
nano-science (Chapters 13 and 14), and novel software tools for application in QSAR studies (Chapter
15). I hope that this book will attract researchers in the field of medicinal chemistry and predictive
toxicology both in the industry and academia.
Kunal Roy
Jadavpur University, India
November 10, 2014
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
xxiii

xxiv
Acknowledgment
I am grateful to the members of the Editorial Advisory Board and the external reviewers for their help
in developing this book. I am also thankful to Prof. L. B. Kier of Virginia Commonwealth University
for writing the Foreword of this book. I also thank the authors for their contributions and the Publisher
for taking an initiative for bringing out this book.
Kunal Roy
Jadavpur University, India
November 10, 2014
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Chapter 1
An Introduction to the
Basic Concepts in QSAR-
Aided Drug Design
Maryam Hamzeh-Mivehroud
Biotechnology Research Center & School of Pharmacy, Tabriz University of Medical Sciences,
Tabriz, Iran
Babak Sokouti
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1
Siavoush Dastmalchi
Biotechnology Research Center & School of Pharmacy, Tabriz University of Medical Sciences,
Tabriz, Iran
ABSTRACT
The need for the development of new drugs to combat existing and newly identified conditions is unavoidable. One of the important tools used in the advanced drug development pipeline is computer-aided drug
design. Traditionally, to find a drug many ligands were synthesized and evaluated for their effectiveness
using suitable bioassays and if all other drug-likeness features were met, the candidate(s) would possibly
reach the market. Although this approach is still in use in advanced format, computational methods are
an indispensable component of modern drug development projects. One of the methods used from very
early days of rationalizing the drug design approaches is Quantitative Structure-Activity Relationship
(QSAR). This chapter overviews QSAR modeling steps by introducing molecular descriptors, mathematical model development for relating biological activities to molecular structures, and model validation.
At the end, several successful cases where QSAR studies were used extensively are presented.
DOI: 10.4018/978-1-4666-8136-1.ch001
Copyright © 2015, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

An Introduction to the Basic Concepts in QSAR-Aided Drug Design
INTRODUCTION
Drug design and discovery is a multidimensional task necessitating collaboration across a broad range
of disciplines and areas of research. Computational drug discovery is an essential component in drug
design process that accelerates drug discovery and development by providing useful preliminary information at the early stages of the process. Quantitative structure-activity relationship (QSAR) is one of
the effective data mining strategies of the computational approaches which have opened up a number of
informative perspectives in modern and profitable drug design process. The chapter will focus on rational
drug design and the importance of relevant computational approaches in this area. Moreover, the chapter
will introduce the QSAR studies as a part of computational methods in drug design and development
processes. Different kinds of molecular descriptors, data analysis, descriptor selection, model building
and evaluation will be discussed. Application of QSAR studies by providing some specific case studies
will also be highlighted.
BACKGROUND
Drugs are vital, essential, and inevitable part of our life which is always being threatened by different
diseases. Therefore, administration of safe and effective drugs is necessary. According to the side effects
being reported in clinic, finding novel drugs with minimum toxicity is always a need. Drug discovery
is a patient-oriented, complex, and time consuming process associated with spending huge amount of
investment and involves many experts from different disciplines such as biology, biochemistry, pharmacology, mathematics, computing and molecular modeling. It has been estimated that of 9.000-10.000
new chemical entities identified or synthesized, one can reach the market within an average time of
16 years. Previously, drugs have been discovered either by identifying chemicals by trial-and-error or
by serendipity. Today, attempts have been focused on rational drug design. Its fundamental principle
lies in logical reasoning before synthesizing any therapeutic agent for the evaluation. In this context,
computer-assisted drug design is a valuable and promising tool in rational drug design and discovery
pipeline and plays an important role in pharmaceutical research by reducing the costly failures of drug
candidates in clinical trials.
One of the strong appeals of QSAR studies deals with chemical safety and risk of toxicity. Toxicological profile and safety assessment of new chemical entities is of paramount importance in drug design
and development process. Compounds with improved biological activity do not necessarily reach the
market and most of them are discarded from clinical trials just for toxicity concerns. Therefore, toxicity is a major source of attrition for potential drug candidates. Drug toxicity and safety assessment of
chemicals is time consuming and is accompanied with spending millions of dollars. In this context,
structure-toxicity predictive models of pharmaceutically relevant molecules can provide an estimation
of risk assessment and safety of drug candidates and it can be regarded as a promising and fundamental
way to reduce the need for animal testing as well as ethical and monetary cost. As a consequence, potentially toxic compounds can be identified during early stages of drug discovery process. Carcinogenicity,
mutagenicity, teratogenicity, hepatotoxicity, cardiotoxicity, and nephrotoxicity are the most important
endpoints in toxicity evaluation (Sullivan, Manuppello, & Willett, 2014; Toropov, Toropova, Raska,
Leszczynska, & Leszczynski, 2014).
2
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

An Introduction to the Basic Concepts in QSAR-Aided Drug Design
Computational approaches can be classified into structure-based drug design (SBDD), ligand-based
drug design (LBDD) and sequence-based approaches (Ou-Yang et al., 2012). In the presence of experimentally determined structure of target molecule, molecular docking and de novo drug design can be
used in the SBDD procedures. In situations in which three dimensional (3D) structure of target molecule is not available, LBDD methods are applied. Quantitative structure-activity relationship (QSAR),
molecular field analysis, pharmacophore modeling, and 2D/3D similarity assessment are examples of
these methods. In the absence of information regarding target and ligand molecules, sequence-based
approaches based on bioinformatics tools are utilized to ultimately find a solution to the drug development problem which may fit in one of the two previously mentioned categories.
QSAR methodology covers data analysis and statistical methods for developing models with
capability of predicting the biological and toxicological activities of compounds based on their
structures. It was first introduced by Corwin H. Hansch (Hansch, Maloney, Fujita, & Muir, 1962).
The basic principle of the technique relies on building mathematical relationship between biological/toxicological activity data of a series of compounds and their structures defined by molecular
descriptors. Molecular descriptors are numerical representations of molecular structures derived
from steric, electronic, constitutional, topological, and geometrical properties of the molecules.
Descriptors used in QSAR hold information about a molecule either as a whole or distinct parts
of it. These descriptors can be experimentally measured or calculated using theoretical methods.
Having descriptors in hand, those with biological relevance should be selected. Different descriptor
selection methods, aimed to determine the best descriptor subset from a large pool of descriptors,
have been proposed to reduce the number of descriptors present in the final mathematical QSAR
model for explaining the biological activities of the studied molecules. These methods can be
classified in three common categories including classical, artificial intelligence based, and miscellaneous methods that are necessary for generalization of predicted QSAR model through training
steps. Multiple linear regression (MLR) analysis and partial least squares (PLS) are the examples
of linear methods whereas artificial neural networks (ANNs) and the k-nearest neighbours (k-NNs)
are few examples for non-linear methods. Generally, linear models predict the biological activity
in a linear function and these models are also easy to interpret compared with non-linear models.
Although, the classical methods can model the linear relationships between structural properties and
biological activities, however, they are not effective in developing models where the relationships
are non-linear. Therefore, in these cases, the descriptor selection methods based on artificial intelligence can easily map existing non-linear relations between structural properties represented by
descriptors and their corresponding biological activity faster and with higher reliability than classical
methods because of their non-linear architecture. As QSAR methods are predictive modeling tools,
the important criterion for evaluating their reliability and validity is to assess the capability of the
models to predict not only the biological activity of the molecules included in training set (internal
validation) but also for the molecules not involved in generating the model (external validation).
Leave-one-out (LOO) and leave-group-out (LGO) are commonly utilized methods for internal cross
validation whereas for external validation method, the predictivity of the QSAR model is judged
based on a separate set of molecules called test set which are not included in model development
in any stage. QSAR has served as a valuable predictive tool for identifying hit compounds, predicting the biological/toxicological activity of untested pharmaceuticals as well as optimizing the lead
compounds for improving the biological activity (shown in Figure 1).
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
3

An Introduction to the Basic Concepts in QSAR-Aided Drug Design
∆G
Figure 1. Pyramid of different steps in QSAR procedure
BIOLOGICAL ACTIVITY DATA
One of the essential constituents of QSAR analysis is biological activity of the compounds under investigation. It is defined as quantitative measurement of the changes brought about by any chemical entity
in the biological process which can provide numerical assessment of potency (Jackson, Esnouf, Winzor,
& Duewer, 2007). Experimental determination of precise and accurate biological activities is of great
importance for generating a meaningful model as they affect the whole process of modeling down the
way substantially. Biological activity obtained from a set of biological assays, should be performed with
great care and evaluated by appropriate statistical treatment to the required satisfaction, e.g., doing the
experiments in triplicates or doublet of triplicates due to response variations. A typical bioassay comprises two components including compound and target of interest like an enzyme, isolated receptors,
animal tissue, cell based assays, and so on. Different kinds of biological and toxicological activities are
used for QSAR studies including affinity data (substrate/receptor binding constant); rate constants such
as association/dissociation and Michaealis Menten constants (
and
IC50; in vitro and in vivo pharmacokinetic and pharmacodynamic rate constants, lethal dose (LD50)
just to mention a few (Kubinyi, 1993). For QSAR analysis, equilibrium/rate constants are well suited as
; ∆G RT K
they are related to Gibbs free energy (
= −2 303. log ;Keq is the equilibrium con-
stant). Therefore, the biological activity should be used in logarithmic scale to fulfill the linear freeenergy relationship (LFER) criteria. The other reason is the normal distribution of the errors of the
activity values when they are presented in the logarithmic scale. Sometimes, the logarithm of reciprocal
biological activity is preferred to use as higher values obtained for potent analogs. The range of bio-
Kd andKm); inhibition constants like Ki
eq
4
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

An Introduction to the Basic Concepts in QSAR-Aided Drug Design
logical activity is important while developing the QSAR models. Full spectrum of activity is required
for a data set and should range at least 3 to 4 orders of magnitude difference between the most and the
least potent compounds. The larger the range, the more reliable QSAR model can be achieved (Scior et
al., 2009). The compounds with poor activity should be incorporated in developing a predictive QSAR
model. However, remotely isolated rare activities may be problematic by causing biases in the developed
model. Since, the data for biological activity are crucial in generating accurate and valid QSAR model,
therefore too much attention should be paid as they are not always as good as they seem at first sight.
CHEMICAL STRUCTURE REPRESENTATION
There are several different ways of representing chemical structures including 2D and 3D representations. 2D structures specify elements, connectivity, and bond order whereas Cartesian coordinates for
each atom is determined in 3D formats. Encoding approaches for 2D representations are line notations,
connection tables and molecular graphs. Line notations are appeared as a sequence of atoms connected
by compact linear string of alphanumeric symbols. The most commonly used line notations are described
as follows. Simplified Molecular Input Line Entry System (SMILES; see Figure 2) is widely used format of notation implemented by Daylight Chemical Information Systems (Santa Fe, NM) (Weininger,
1988; Weininger, Weininger, & Weininger, 1989). SYBYL Line Notation (SLN) developed by Tripos
Inc. provides richer set of information for molecular queries, stereochemistry, and reactions (Figure 2).
The other line notation introduced recently is InChI stands for IUPAC international chemical identifier.
This format of representation provides a unique line notation consisting of six layers, each identifying a
distinctive structural property about the molecule. The layers are main layer, a charge layer, stereochemical layer, an isotopic layer, a fixed-H, and a reconnected layer. The presence of main layer, which specifies atom and bond types, is required but the others are optional (Warr, 2011; Young, 2009). The other
molecular line notations are Wiswesser Line-Formula Notation (WLN) and representation of structure
diagram arranged linearly (ROSDAL). Figure 2 shows different line notation formats for phenylalanine
as an example (Warr, 2011).
Connection tables are the other types of encoding style, in which the chemical structure is defined as
a table of atom and bond types connecting the atoms with given arbitrary number in a series. Relative
coordinates for each atom are usually included. An example of most commonly used connection table
in Molfile format is shown in Figure 3.
Registry systems like Chemical Abstract Service Registry Number (CAS RN) are database of disclosed chemical substance information. Although it is a method of naming structures and provides no
chemical information, however, it can be converted to machine readable structures by several programs
2
such as ACD/Labs
Germany) (Warr, 2011).
The other method for representing the chemical structures in 2D format is the molecular graph.
Molecular graphs are derived from the graph theory; a theory not only used in chemistry but also in
computer and related sciences. This theory is a branch of mathematics that defines the sets of objects by
nodes and the corresponding relationships between them called edges. Atoms and bonds are considered
as nodes and edges, respectively, in a molecular graph. For a molecular graph some properties like atom
type (for nodes) and bond order (for edges) can be represented. Generally, the molecular graph shows
the topology of the molecule and the way the atoms are connected (Figure 4).
(Toronto, Canada), CambridgeSoft3 (Cambridge, MA), and InfoChem4 (Munich,
1
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
5
Соседние файлы в папке Библиотека им академика М.И. Перельмана
